DNA origamis to revolutionize rapid diagnostics
Germany
aliveunknown
unknown
Stage
1
Investors
About
Amplifold develops a DNA origami platform for rapid diagnostic tests, with focus on reducing false negatives in cardiac, respiratory, and stroke detection.
Explore DNA origamis to revolutionize rapid diagnostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.